Indian generic manufacturers will produce lenacapavir, a near 100% effective, six-month injectable HIV prevention drug, ...

Without clear timelines and accountability, Ireland risks falling short of its goal to end new HIV transmissions by 2030.

Knowing how to leverage these technologies means we can help set the new standard and inform the next evolution of HIV care.

A partnership will enable low-cost, generic lenacapavir for HIV prevention in LMICs, aiming to improve access and reduce infections significantly.

The twice-yearly drug has been hailed as a medical breakthrough that could change the course of the HIV epidemic.View on ...

A single injection of Lenacapvir offers protection for six months, a breakthrough especially for women who often face ...

The White House details its Gaza peace deal plan. No breakthrough after Trump’s meeting with Democrats to avert a government ...

The announcement comes at a troubling time for global health, particularly in the fight against HIV/AIDS, as US foreign aid ...

The United Nations agency focusing on the HIV/AIDS pandemic could close by the end of next year as the U.N. restructures in ...

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...

New partnership will join others to expand access to generic lenacapavir for millions more people at risk of HIV in high-burden countries—bringing the world closer to ending the epidemic - Kenya ...